#5 - Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance (WBA) Walgreens (NASDAQ:WBA) stock is off to a rough start in 2020, but now may be an opportunity for the stock to shine. In the first place, the company’s revenue is increasing. The company’s total revenue has grown at a CAGR of 5.4% between 2016 through 2019. And this revenue was primarily driven through the company’s pharmacy business.
That looks to continue be a driver for the business in 2020 with the company expecting the pharmacy to contribute $84 billion to the company’s fiscal 2020 revenues. That would account for nearly 60%. It’s reasonable to expect that Walgreen’s may get a boost from ancillary sales as consumers stock up on other products as they fill prescriptions.
Walgreen’s Boots Alliance has a dividend yield of 4.10% and pays an annual dividend of $1.83 per share. The company has increased its dividend by an average of 5.69% annually for the past three years and has 44 consecutive years of annual dividend growth.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More - Current Price
- $8.66
- Consensus Rating
- Reduce
- Ratings Breakdown
- 2 Buy Ratings, 9 Hold Ratings, 4 Sell Ratings.
- Consensus Price Target
- $12.88 (48.8% Upside)
